Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer
Research output: Contribution to journal › Article › Scientific › peer-review
102Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer'. Together they form a unique fingerprint.